| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Urs P Mosimann, Elise N Rowan, Cassie E Partington, Daniel Collerton, Elizabeth Littlewood, John T O'Brien, David J Burn, Ian G McKeit. Characteristics of visual hallucinations in Parkinson disease dementia and dementia with lewy bodies. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry. vol 14. issue 2. 2006-05-11. PMID:16473980. |
parkinson disease dementia (pdd) and dementia with lewy bodies (dlb) have overlapping clinical and pathologic features. |
2006-05-11 |
2023-08-12 |
Not clear |
| Brit Mollenhauer, Mirko Bibl, Jens Wiltfang, Petra Steinacker, Barbara Ciesielczyk, Karin Neubert, Claudia Trenkwalder, Markus Ott. Total tau protein, phosphorylated tau (181p) protein, beta-amyloid(1-42), and beta-amyloid(1-40) in cerebrospinal fluid of patients with dementia with Lewy bodies. Clinical chemistry and laboratory medicine. vol 44. issue 2. 2006-05-05. PMID:16475906. |
for tau protein and beta-amyloid(1-42) in cerebrospinal fluid (csf), promising results for the diagnosis of alzheimer's disease (ad) have been reported; however, their differential diagnostic spectrum is limited, as was recently shown for dementia with lewy bodies (dlb) and for ad. |
2006-05-05 |
2023-08-12 |
Not clear |
| Brit Mollenhauer, Mirko Bibl, Jens Wiltfang, Petra Steinacker, Barbara Ciesielczyk, Karin Neubert, Claudia Trenkwalder, Markus Ott. Total tau protein, phosphorylated tau (181p) protein, beta-amyloid(1-42), and beta-amyloid(1-40) in cerebrospinal fluid of patients with dementia with Lewy bodies. Clinical chemistry and laboratory medicine. vol 44. issue 2. 2006-05-05. PMID:16475906. |
all markers could differentiate between the dementia groups (ad, dlb) and the controls. |
2006-05-05 |
2023-08-12 |
Not clear |
| F Lebert, E Le Rhu. [Treatment of dementia with Lewy bodies]. Revue neurologique. vol 162. issue 1. 2006-05-03. PMID:16446631. |
dementia with lewy bodies (dlb) is known for its partial resistance and hypersensitivity to some treatments, but dlb is treatable with cholinesterase inhibitors, sometimes better than in alzheimer's disease. |
2006-05-03 |
2023-08-12 |
Not clear |
| J M Miyasaki, K Shannon, V Voon, B Ravina, G Kleiner-Fisman, K Anderson, L M Shulman, G Gronseth, W J Weine. Practice Parameter: evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. vol 66. issue 7. 2006-05-02. PMID:16606910. |
3) what are effective treatments for pd dementia or dementia with lewy bodies (dlb)? |
2006-05-02 |
2023-08-12 |
Not clear |
| Kurt A Jellinge. Pathological substrate of dementia in Parkinson's disease--its relation to DLB and DLBD. Parkinsonism & related disorders. vol 12. issue 2. 2006-05-01. PMID:16337163. |
pathological substrate of dementia in parkinson's disease--its relation to dlb and dlbd. |
2006-05-01 |
2023-08-12 |
Not clear |
| Elizabeta B Mukaetova-Ladinska, Ian G McKeit. Pathophysiology of synuclein aggregation in Lewy body disease. Mechanisms of ageing and development. vol 127. issue 2. 2006-04-21. PMID:16297436. |
we provide an overview of synaptic pathology in dementia with lewy bodies (dlb) and related neurodegenerative disorders that are characterised by intraneuronal accumulation of alpha-synuclein aggregates. |
2006-04-21 |
2023-08-12 |
Not clear |
| T Mori, M Ikeda, R Fukuhara, P J Nestor, H Tanab. Correlation of visual hallucinations with occipital rCBF changes by donepezil in DLB. Neurology. vol 66. issue 6. 2006-04-20. PMID:16567718. |
the authors explored the neural substrate of visual hallucinations in dementia with lewy bodies (dlb) by investigating changes in regional cerebral blood flow (rcbf) and psychiatric symptoms, before and after cholinesterase inhibitor treatment. |
2006-04-20 |
2023-08-12 |
human |
| I G McKeith, D W Dickson, J Lowe, M Emre, J T O'Brien, H Feldman, J Cummings, J E Duda, C Lippa, E K Perry, D Aarsland, H Arai, C G Ballard, B Boeve, D J Burn, D Costa, T Del Ser, B Dubois, D Galasko, S Gauthier, C G Goetz, E Gomez-Tortosa, G Halliday, L A Hansen, J Hardy, T Iwatsubo, R N Kalaria, D Kaufer, R A Kenny, A Korczyn, K Kosaka, V M Y Lee, A Lees, I Litvan, E Londos, O L Lopez, S Minoshima, Y Mizuno, J A Molina, E B Mukaetova-Ladinska, F Pasquier, R H Perry, J B Schulz, J Q Trojanowski, M Yamad. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology. vol 65. issue 12. 2006-04-14. PMID:16237129. |
diagnosis and management of dementia with lewy bodies: third report of the dlb consortium. |
2006-04-14 |
2023-08-12 |
Not clear |
| I G McKeith, D W Dickson, J Lowe, M Emre, J T O'Brien, H Feldman, J Cummings, J E Duda, C Lippa, E K Perry, D Aarsland, H Arai, C G Ballard, B Boeve, D J Burn, D Costa, T Del Ser, B Dubois, D Galasko, S Gauthier, C G Goetz, E Gomez-Tortosa, G Halliday, L A Hansen, J Hardy, T Iwatsubo, R N Kalaria, D Kaufer, R A Kenny, A Korczyn, K Kosaka, V M Y Lee, A Lees, I Litvan, E Londos, O L Lopez, S Minoshima, Y Mizuno, J A Molina, E B Mukaetova-Ladinska, F Pasquier, R H Perry, J B Schulz, J Q Trojanowski, M Yamad. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology. vol 65. issue 12. 2006-04-14. PMID:16237129. |
the dementia with lewy bodies (dlb) consortium has revised criteria for the clinical and pathologic diagnosis of dlb incorporating new information about the core clinical features and suggesting improved methods to assess them. |
2006-04-14 |
2023-08-12 |
Not clear |
| I G McKeith, D W Dickson, J Lowe, M Emre, J T O'Brien, H Feldman, J Cummings, J E Duda, C Lippa, E K Perry, D Aarsland, H Arai, C G Ballard, B Boeve, D J Burn, D Costa, T Del Ser, B Dubois, D Galasko, S Gauthier, C G Goetz, E Gomez-Tortosa, G Halliday, L A Hansen, J Hardy, T Iwatsubo, R N Kalaria, D Kaufer, R A Kenny, A Korczyn, K Kosaka, V M Y Lee, A Lees, I Litvan, E Londos, O L Lopez, S Minoshima, Y Mizuno, J A Molina, E B Mukaetova-Ladinska, F Pasquier, R H Perry, J B Schulz, J Q Trojanowski, M Yamad. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology. vol 65. issue 12. 2006-04-14. PMID:16237129. |
the 1-year rule distinguishing between dlb and parkinson disease with dementia may be difficult to apply in clinical settings and in such cases the term most appropriate to each individual patient should be used. |
2006-04-14 |
2023-08-12 |
Not clear |
| Manuel Menendez-Gonzalez, Maria Teresa Calatayud, Bernardino Blazquez-Mene. Exacerbation of Lewy bodies dementia due to memantine. Journal of Alzheimer's disease : JAD. vol 8. issue 3. 2006-04-14. PMID:16340086. |
lewy body dementia (dlb) is common but frequently misdiagnosed as alzheimer's disease plus delirium or parkinsonism. |
2006-04-14 |
2023-08-12 |
Not clear |
| Iryna Ziabreva, Clive G Ballard, Dag Aarsland, Jan-Petter Larsen, Ian G McKeith, Robert H Perry, Elaine K Perr. Lewy body disease: thalamic cholinergic activity related to dementia and parkinsonism. Neurobiology of aging. vol 27. issue 3. 2006-04-13. PMID:15913843. |
within the spectrum of lewy body disease cognitive impairment occurs in pd with dementia (pdd) and dementia with lewy bodies (dlb). |
2006-04-13 |
2023-08-12 |
Not clear |
| Iryna Ziabreva, Clive G Ballard, Dag Aarsland, Jan-Petter Larsen, Ian G McKeith, Robert H Perry, Elaine K Perr. Lewy body disease: thalamic cholinergic activity related to dementia and parkinsonism. Neurobiology of aging. vol 27. issue 3. 2006-04-13. PMID:15913843. |
choline acetyltransferase (chat) activity was analyzed in reticular (re), mediodorsal (md) and centromedian (cm) thalamic nuclei in series of nine controls, five dlb with parkinsonism (dlb + p), five dlb without parkinsonism (dlb - p), six pd without dementia and 14 pdd cases. |
2006-04-13 |
2023-08-12 |
Not clear |
| Iryna Ziabreva, Clive G Ballard, Dag Aarsland, Jan-Petter Larsen, Ian G McKeith, Robert H Perry, Elaine K Perr. Lewy body disease: thalamic cholinergic activity related to dementia and parkinsonism. Neurobiology of aging. vol 27. issue 3. 2006-04-13. PMID:15913843. |
increased chat activity was found in cm nuclei in dlb + p compared with dlb - p. these findings show that significant thalamic presynaptic cholinergic deficits occur only in cases of combined cortical and subcortical neurodegeneration in which dementia developed after prolonged parkinsonism. |
2006-04-13 |
2023-08-12 |
Not clear |
| Paul M Kemp, Sandra A Hoffmann, Clive Holmes, Livia Bolt, Tony Ward, Robin B Holmes, John S Flemin. The contribution of statistical parametric mapping in the assessment of precuneal and medial temporal lobe perfusion by 99mTc-HMPAO SPECT in mild Alzheimer's and Lewy body dementia. Nuclear medicine communications. vol 26. issue 12. 2006-04-10. PMID:16264357. |
to assess the role of 99mtc-hexamethylpropyleneamine oxime single-photon emission computed tomography (99mtc-hmpao spect) imaging of the precuneus and medial temporal lobe in the individual patient with mild alzheimer's disease and dementia with lewy bodies (dlb) using statistical parametric mapping and visual image interpretation. |
2006-04-10 |
2023-08-12 |
Not clear |
| Masahiko Suzuki, Akira Kurita, Masaya Hashimoto, Nobuyoshi Fukumitsu, Masahiro Abo, Yasuhiko Ito, Mitsuyoshi Urashima, Kiyoharu Inou. Impaired myocardial 123I-metaiodobenzylguanidine uptake in Lewy body disease: comparison between dementia with Lewy bodies and Parkinson's disease. Journal of the neurological sciences. vol 240. issue 1-2. 2006-03-29. PMID:16199056. |
iodine-123-labeled metaiodobenzylguanidine (123i-mibg) myocardial scintigraphy has been used to evaluate cardiac sympathetic denervation in lewy body disease (lbd) including parkinson's disease (pd) and dementia with lewy bodies (dlb). |
2006-03-29 |
2023-08-12 |
Not clear |
| Patricia Szot, Sylvia S White, J Lynne Greenup, James B Leverenz, Elaine R Peskind, Murray A Raskin. Compensatory changes in the noradrenergic nervous system in the locus ceruleus and hippocampus of postmortem subjects with Alzheimer's disease and dementia with Lewy bodies. The Journal of neuroscience : the official journal of the Society for Neuroscience. vol 26. issue 2. 2006-03-17. PMID:16407544. |
because the noradrenergic system plays an important role in learning and memory, it is important to determine whether compensation occurs in noradrenergic neurons in the lc and hippocampus of subjects with ad or a related dementing disorder, dementia with lewy bodies (dlb). |
2006-03-17 |
2023-08-12 |
human |
| Pietro Tiraboschi, David P Salmon, Lawrence A Hansen, Richard C Hofstetter, Leon J Thal, Jody Corey-Bloo. What best differentiates Lewy body from Alzheimer's disease in early-stage dementia? Brain : a journal of neurology. vol 129. issue Pt 3. 2006-03-15. PMID:16401618. |
to determine which clinical feature(s) [among visual hallucinations (vh), extrapyramidal signs (eps) and visuospatial impairment] in the earliest stages of disease best predicted a diagnosis of dementia with lewy bodies (dlb) at autopsy, first-visit data of 23 pathologically proven dlb and 94 alzheimer's disease cases were compared. |
2006-03-15 |
2023-08-12 |
Not clear |
| Sebastiaan Engelborghs, Bart Dermaut, Peter Mariën, Anoek Symons, Ellen Vloeberghs, Karen Maertens, Nore Somers, Johan Goeman, Rosa Rademakers, Marleen Van den Broeck, Barbara Pickut, Marc Cruts, Christine Van Broeckhoven, Peter P De Dey. Dose dependent effect of APOE epsilon4 on behavioral symptoms in frontal lobe dementia. Neurobiology of aging. vol 27. issue 2. 2006-03-14. PMID:16399213. |
patients with alzheimer's disease (ad) (n=186), frontotemporal dementia (ftd) (n=29), mixed dementia (mxd) (n=28), dementia with lewy bodies (dlb) (n=11) and parkinson's disease dementia (pdd) (n=7) were included. |
2006-03-14 |
2023-08-12 |
Not clear |